In an article titled “Amazon MGM Studios’ Debra Birnbaum Joins Ovarian Cancer Research Alliance Board,” Variety editor William Earl writes about MGM Studios’ Debra Birnbaum’s appointment to Ovarian Cancer Research Alliance’s board of directors. An ovarian cancer survivor, Debra Birnbaum talks about what inspired her to join OCRA, and what she hopes to accomplish for those impacted by the disease.
Related Topics
The Overview: November 2025
Friends, As we approach the end of the year, one thing stands out above all else: this is a moment of unprecedented opportunity to accelerate progress against ovarian and all gynecologic cancers. And thanks to you, OCRA is rising to meet that moment — driving innovation, expanding support, and providing the community that so many … Continued
OCRA Board Member Laura Shawver, PhD, Named to Fierce 50 of 2025
Ovarian Cancer Research Alliance (OCRA) congratulates board member Laura Shawver, PhD, on her selection to the Fierce 50 of 2025, a leading industry award from Fierce Life Sciences recognizing individuals and organizations advancing what’s possible in health, science and patient care. Dr. Shawver was selected for her long-standing leadership in oncology research and drug development, … Continued
Make 2X the Difference with OCRA this Giving Season
YOU Can Help Shape the Future of Ovarian and Gynecologic Cancer Care We need your help to reach our important $2 million year-end fundraising goal. Your donation will be matched up to $500,000 through 12/31, thanks to a generous OCRA board member. That means your $1 = $2 to improve care, foster hope, and bring … Continued